Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited has informed the BSE that the trading window for dealing in its securities will remain closed for insiders, directors, and designated persons from Tuesday, 1st July 2025. The window will reopen only 48 hours after the announcement of financial results for the first quarter ended 30th June 2025. This closure is in line with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's own insider trading code. The company has also stated that the date of the upcoming board meeting to consider the Q1 results will be communicated later. The intimation was signed by Director Ramanlal Nagjibhai Trivedi on 26th June 2025.
This is a routine compliance filing with no direct impact on the stock price. However, it signals that the company's Q1 FY26 results are expected soon, which investors should watch for as it could drive near-term price action.